APA (7th ed.) Citation

F, N., I, P. d. S., PA, J., AM, M., JS, W., V, A., . . . GV, L. (2022). Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance. Cancer cell, 40(1), 88. https://doi.org/10.1016/j.ccell.2021.11.012

Chicago Style (17th ed.) Citation

F, Newell, et al. "Multiomic Profiling of Checkpoint Inhibitor-treated Melanoma: Identifying Predictors of Response and Resistance, and Markers of Biological Discordance." Cancer Cell 40, no. 1 (2022): 88. https://doi.org/10.1016/j.ccell.2021.11.012.

MLA (9th ed.) Citation

F, Newell, et al. "Multiomic Profiling of Checkpoint Inhibitor-treated Melanoma: Identifying Predictors of Response and Resistance, and Markers of Biological Discordance." Cancer Cell, vol. 40, no. 1, 2022, p. 88, https://doi.org/10.1016/j.ccell.2021.11.012.